Cargando…

HIV/AIDS treatment and prevention in India : modeling the costs and consequences /

This title projects the future implications of three alternative AIDS treatment financing policies for the health burden of AIDS in India and for its overall health expenditures. Written by an interdisciplinary team of AIDS experts, the book presents new data on the supply and demand for antiretrovi...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: World Bank
Otros Autores: Over, A. Mead
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, DC : World Bank, 2004.
Colección:Health, nutrition, and population series.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocm56125927
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu|||unuuu
008 040810s2004 dcua ob i001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d YDXCP  |d OCLCQ  |d CUS  |d OCLCQ  |d TUU  |d OCLCQ  |d OCLCF  |d DKDLA  |d OCLCQ  |d REDDC  |d BAKER  |d LGG  |d PUL  |d ZCU  |d QT5  |d MERUC  |d CCO  |d E7B  |d FVL  |d OCLCQ  |d IDEBK  |d AU@  |d BWS  |d EBLCP  |d DEBSZ  |d OCLCQ  |d AZK  |d CNNOR  |d SUR  |d MOR  |d PIFBR  |d OCLCQ  |d SAV  |d OCLCQ  |d WY@  |d U3W  |d LUE  |d CAUOI  |d YDX  |d BRL  |d STF  |d WRM  |d OCLCQ  |d CEF  |d OCLCA  |d NRAMU  |d ICG  |d INT  |d VT2  |d TOF  |d OCLCQ  |d WYU  |d G3B  |d TKN  |d A6Q  |d MERER  |d OCLCQ  |d DKC  |d OCLCQ  |d HS0  |d OCLCQ  |d UWK  |d YOU  |d OCLCQ  |d CHBRC  |d OCLCQ  |d UKCRE  |d AJS  |d OCLCQ  |d OCLCO  |d SDF  |d TUHNV  |d OCLCO  |d OCL  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 70756478  |a 478352834  |a 508010026  |a 531339995  |a 559606853  |a 630213431  |a 646720119  |a 722290667  |a 728023688  |a 813538113  |a 827879806  |a 910087118  |a 961649277  |a 961693342  |a 962654007  |a 962686638  |a 984865423  |a 988502705  |a 991936999  |a 992048482  |a 1029487907  |a 1037506107  |a 1037908607  |a 1038664067  |a 1045491542  |a 1045520612  |a 1053069082  |a 1055319538  |a 1063814829  |a 1083560306  |a 1088965441  |a 1109076842  |a 1110405016  |a 1120928429  |a 1135436618  |a 1153479633  |a 1162088711  |a 1200913993  |a 1202541240  |a 1227629313  |a 1228605491  |a 1290083883  |a 1300799357 
020 |a 1417534214  |q (electronic bk.) 
020 |a 9781417534210  |q (electronic bk.) 
020 |a 0821356577 
020 |a 9780821356579 
020 |a 6610084688 
020 |a 9786610084685 
020 |a 1280084685 
020 |a 9781280084683 
029 1 |a AU@  |b 000049070757 
029 1 |a AU@  |b 000053233797 
029 1 |a AU@  |b 000065666978 
029 1 |a DEBBG  |b BV044093505 
029 1 |a DEBSZ  |b 449594068 
029 1 |a NZ1  |b 11988425 
029 1 |a NZ1  |b 15294277 
035 |a (OCoLC)56125927  |z (OCoLC)70756478  |z (OCoLC)478352834  |z (OCoLC)508010026  |z (OCoLC)531339995  |z (OCoLC)559606853  |z (OCoLC)630213431  |z (OCoLC)646720119  |z (OCoLC)722290667  |z (OCoLC)728023688  |z (OCoLC)813538113  |z (OCoLC)827879806  |z (OCoLC)910087118  |z (OCoLC)961649277  |z (OCoLC)961693342  |z (OCoLC)962654007  |z (OCoLC)962686638  |z (OCoLC)984865423  |z (OCoLC)988502705  |z (OCoLC)991936999  |z (OCoLC)992048482  |z (OCoLC)1029487907  |z (OCoLC)1037506107  |z (OCoLC)1037908607  |z (OCoLC)1038664067  |z (OCoLC)1045491542  |z (OCoLC)1045520612  |z (OCoLC)1053069082  |z (OCoLC)1055319538  |z (OCoLC)1063814829  |z (OCoLC)1083560306  |z (OCoLC)1088965441  |z (OCoLC)1109076842  |z (OCoLC)1110405016  |z (OCoLC)1120928429  |z (OCoLC)1135436618  |z (OCoLC)1153479633  |z (OCoLC)1162088711  |z (OCoLC)1200913993  |z (OCoLC)1202541240  |z (OCoLC)1227629313  |z (OCoLC)1228605491  |z (OCoLC)1290083883  |z (OCoLC)1300799357 
043 |a a-ii--- 
050 4 |a RA643.86.I42  |b H58 2004eb 
060 4 |a WC 503.4 JI4  |b H58 2004eb 
072 7 |a MED  |x 076000  |2 bisacsh 
072 7 |a MED  |x 030000  |2 bisacsh 
072 7 |a MED  |x 078000  |2 bisacsh 
072 7 |a MBP  |2 bicssc 
082 0 4 |a 614.5993920934  |2 22 
049 |a UAMI 
245 0 0 |a HIV/AIDS treatment and prevention in India :  |b modeling the costs and consequences /  |c Mead Over [and others]. 
260 |a Washington, DC :  |b World Bank,  |c 2004. 
300 |a 1 online resource (xxix, 121 pages) :  |b illustrations. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
490 1 |a Health, nutrition, and population series 
500 |a Accompanying CD-ROM in back pocket contains background papers in Microsoft Word format and code for the epidemic models used in the book. 
504 |a Includes bibliographical references and index. 
520 |a This title projects the future implications of three alternative AIDS treatment financing policies for the health burden of AIDS in India and for its overall health expenditures. Written by an interdisciplinary team of AIDS experts, the book presents new data on the supply and demand for antiretroviral treatment in India and new models of the epidemiological effects and the financial costs of alternative policies. 
588 0 |a Print version record. 
505 0 |a Foreword -- Acknowledgments -- Executive Summary -- List of Acronyms and Abbreviations -- 1. Introduction -- Antiretroviral Therapy -- Scope of the Report -- 2. India's HIV/AIDS Epidemic -- The Epidemiology of HIV in India -- Responses to the Epidemic -- 3. HIV/AIDS and Antiretroviral Therapy -- Treating Opportunistic Illnesses with or without Antiretroviral Therapy -- Toxicity, Adherence, and the Development of Resistance as a Result of Antiretroviral Drug Therapy -- Monitoring the Progress of HIV/AIDS Disease and the Efficacy of Antiretroviral Therapy. 
505 8 |a Biological and Behavioral Effects of Antiretroviral Therapy on Transmission -- 4. Projecting the Course of India's HIV/AIDS Epidemic without Policy Change -- A Framework for Analyzing Antiretroviral Therapy Policy -- Structure of the Epidemiological Projection Model -- 5. Evaluating the Costs and Consequences of Alternative Government Policies -- Comparison of Policy Options Assuming Antiretroviral Therapy Has No Effect on Risk Behavior -- Comparison of Baseline and Below the Poverty Line Policy Assuming Antiretroviral Therapy Affects Risk Behavior. 
505 8 |a Cost-Effectiveness of Alternative Antiretroviral Therapy Policies -- 6. Recommendations and Conclusions -- Index -- List of Boxes -- 1-1 Is Government Financing of AIDS Treatment in Poor Countries Ethical? -- 2-1 Sources, Limitations, and Assumptions behind Current Estimates of HIV Incidence and Prevalence in India, 2002 -- 3-1 WHO Guidelines on First- and Second-Line Antiretroviral Therapy -- 4-1 Performance-Based Fiscal Mechanisms in India -- 4-2 International Experience with Government-Financed Antiretroviral Therapy -- List of Tables. 
505 8 |a 2-1 Estimated Number of People with HIV/AIDS, by State, 2002 -- 2-2 Estimated Number of People with AIDS in 60 Indian Cities, 2002 -- 2-3 Financing of India 's National HIV/AIDS Control Program, circa 2002 -- 2-4 Financing of Curative Health Services in India -- 2-5 Prices of Patented Drugs in India and Selected Other Countries, Mid-1990s -- 3-1 Minimum Risk of Contracting HIV through Sexual Contact, Mother-to-Child Transmission, and Blood or Blood Products -- 3-2 Life Expectancy from Structured and Unstructured Antiretroviral Therapy. 
505 8 |a 3-3 Possible Beneficial and Adverse Effects of Antiretroviral Therapy on HIV Transmission -- 4-1 Cost and Timing of Treating Opportunistic Illnesses of Average Indian with HIV under Different Antiretroviral Treatment Regimes (circa 2002) -- 4-2 Opportunity Cost of Antiretroviral Therapy in Terms of Forgone HIV/AIDS Prevention -- 5-1 Projected Impact of ADHERE Policy in India, 1998-2033 -- 5-2 Projected Impact of MTCT+ Policy in India, 1998-2033 -- 5-3 Projected Impact of Below the Poverty Line Policy in India, 1998-2033 -- List of Figures. 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a AIDS (Disease)  |z India. 
650 0 |a Cost effectiveness. 
650 2 |a Acquired Immunodeficiency Syndrome  |x epidemiology 
650 2 |a HIV Infections  |x epidemiology 
650 2 |a Acquired Immunodeficiency Syndrome  |x drug therapy 
650 2 |a Acquired Immunodeficiency Syndrome  |x economics 
650 2 |a Antiretroviral Therapy, Highly Active  |x economics 
650 2 |a Cost-Benefit Analysis 
650 2 |a HIV Infections  |x drug therapy 
650 2 |a HIV Infections  |x economics 
650 2 |a Health Policy  |x economics 
650 2 |a Models, Economic 
651 2 |a India 
650 6 |a Sida  |z Inde. 
650 6 |a Coût-efficacité. 
650 7 |a cost benefit analysis.  |2 aat 
650 7 |a MEDICAL  |x Preventive Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Forensic Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Public Health.  |2 bisacsh 
650 7 |a Cost effectiveness  |2 fast 
650 7 |a AIDS (Disease)  |2 fast 
651 7 |a India  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJmdx47cDXrRhBXHtbvPwC 
700 1 |a Over, A. Mead. 
710 2 |a World Bank. 
758 |i has work:  |a HIV/AIDS treatment and prevention in India (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCH8XgJ6mqCp4XhPHWrFyq3  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t HIV/AIDS treatment and prevention in India.  |d Washington, DC : World Bank, 2004  |z 0821356577  |w (OCoLC)55893389 
830 0 |a Health, nutrition, and population series. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3050714  |z Texto completo 
938 |a Baker & Taylor  |b BKTY  |c 15.00  |d 15.00  |i 0821356577  |n 0004363139  |s active 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3050714 
938 |a EBSCOhost  |b EBSC  |n 117002 
938 |a YBP Library Services  |b YANK  |n 15359578 
938 |a YBP Library Services  |b YANK  |n 2350908 
994 |a 92  |b IZTAP